173 related articles for article (PubMed ID: 34928559)
1. Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia.
Strømme MF; Mellesdal LS; Bartz-Johannesen CA; Kroken RA; Krogenes ML; Mehlum L; Johnsen E
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):37-42. PubMed ID: 34928559
[TBL] [Abstract][Full Text] [Related]
2. Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia.
Strømme MF; Bartz-Johannesen C; Kroken RA; Mehlum L; Johnsen E
Schizophr Res; 2022 Oct; 248():35-41. PubMed ID: 35933742
[TBL] [Abstract][Full Text] [Related]
3. Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study.
Strømme MF; Mellesdal LS; Bartz-Johannesen C; Kroken RA; Krogenes M; Mehlum L; Johnsen E
Schizophr Res; 2021 Sep; 235():29-35. PubMed ID: 34303258
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Tan Z; Wall MM; Mathai C; Olfson M
JAMA Psychiatry; 2019 May; 76(5):508-515. PubMed ID: 30785609
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
7. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.
Tiihonen J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Am J Psychiatry; 2016 Jun; 173(6):600-6. PubMed ID: 26651392
[TBL] [Abstract][Full Text] [Related]
8. Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.
Puranen A; Koponen M; Tanskanen A; Tiihonen J; Taipale H
Eur J Clin Pharmacol; 2020 May; 76(5):711-718. PubMed ID: 31940085
[TBL] [Abstract][Full Text] [Related]
9. Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine.
Kesserwani J; Kadra G; Downs J; Shetty H; MacCabe JH; Taylor D; Stewart R; Chang CK; Hayes RD
J Psychopharmacol; 2019 Apr; 33(4):449-458. PubMed ID: 30616489
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for early readmission to acute care for persons with schizophrenia taking antipsychotic medications.
Boaz TL; Becker MA; Andel R; Van Dorn RA; Choi J; Sikirica M
Psychiatr Serv; 2013 Dec; 64(12):1225-9. PubMed ID: 23945797
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
12. Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study.
Osler M; Jørgensen MB
Am J Psychiatry; 2020 Jun; 177(6):497-505. PubMed ID: 32252539
[TBL] [Abstract][Full Text] [Related]
13. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
[TBL] [Abstract][Full Text] [Related]
14. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
[TBL] [Abstract][Full Text] [Related]
15. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.
Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM
Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277
[TBL] [Abstract][Full Text] [Related]
16. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
[TBL] [Abstract][Full Text] [Related]
17. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.
Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtälä J; Lähteenvuo M
Lancet Psychiatry; 2017 Jul; 4(7):547-553. PubMed ID: 28578901
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.
Tiihonen J; Suokas JT; Suvisaari JM; Haukka J; Korhonen P
Arch Gen Psychiatry; 2012 May; 69(5):476-83. PubMed ID: 22566579
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
